Sionna Therapeutics’ Post

View organization page for Sionna Therapeutics, graphic

4,205 followers

Our SVP of Global Regulatory Affairs and Quality, Mara Furlow, shares her excitement about Sionna's potential to make a difference in the lives of people with cystic fibrosis (#CF).

  • No alternative text description for this image
Shekhar Natarajan MSc FRSC FTOPRA

Vice President Regulatory Affairs | Rare Disease Advocate | Member of British Pharmacopoeia Commission's Expert Advisory Group (EAG) | Board Advisor | Trustee

2mo

Great to see this Mara, more hope for people living with CF.

Darren Nelson 🚀 (We're hiring)

Helping Life Sciences & Technology companies find top talent through personalized recruitment solutions.

2mo

It’s inspiring to hear Mara Furlow’s enthusiasm about Sionna’s mission to impact the lives of those with cystic fibrosis. The dedication to advancing treatments in such a crucial area highlights the meaningful work being done at Sionna. Looking forward to seeing the progress and positive changes ahead!

Like
Reply
Sam Gentile

Total Rewards Leader | HR Strategist | Business Partner | DEI Advocate | Project Management

2mo

You're amazing Mara 💙 they're so lucky to have you!

Theresa Hillmer-Waite

Associate Executive Director at Cystic Fibrosis Foundation

1mo

Congratulations! Thank you for striving to make a difference in people's lives.

Like
Reply
Maria Iacovelli

Senior Director, GRS CMC Cerevel Therapeutics

1mo

Nice work Mara! I hope all is well.

Mary S.

Human Resource Business Partner

1mo

This is exciting news!

Like
Reply
Harris Rotman

Senior Vice President of Regulatory Affairs at Madrigal Pharmaceuticals

2mo

Congrats!

Jerry Cahill

Advocate - CF/Rare Disease/Organ Awareness, Founder You Cannot Fail Group

1mo

Congratulations!

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics